Cara: Q1 Earnings Snapshot
By Ap News
Published - May 13, 2024, 04:09 PM ET
Last Updated - May 13, 2024, 04:09 PM EDT
STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — Cara Therapeutics Inc. (CARA) on Monday reported a loss of $30.7 million in its first quarter.
On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 56 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 38 cents per share.
The biotechnology company posted revenue of $2.1 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $2.3 million.
